Altimmune, Inc. is a company in the U.S. stock market and it is a holding in 16 U.S.-traded ETFs. ALT has around 862.1K shares in the U.S. ETF market. The largest ETF holder of ALT is the iShares Biotechnology ETF (IBB), with approximately 319.55K shares. Investors may also find of interest that the ETF with the largest allocation to ALT stock is ETFMG Treatments Testing and Advancements ETF (GERM), with a portfolio weight of 0.59%. On average, U.S. ETFs allocate 0.08% of ALT to their portfolios.
Additionally, ALT is a favorite stock for Active and Vanilla ETFs. It is also most likely to belong to Broad-based ETFs. The best-performing ETF in the past 12 months with ALT as a holding is the Avantis U.S. Small Cap Equity ETF (AVSC), with a return of --.